NASDAQ

Celularity Inc. - Class A (CELU)

599 Thanks from members

Celularity Inc. (CELU) faces intense financial distress, marked by a going concern warning, severe shareholder dilution, and micro-cap volatility, offset slightly by its placenta-based regenerative asset portfolio and commercial biomaterials footprint.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →